Jilong Liu
Jilong Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Guodong Li
Tongji University
1 shared publication - Huazong Zeng
Shanghai Sensichip Co Ltd, Shanghai 200433, PR China
1 shared publication - Lei Chen
The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
1 shared publication - Wenjing Wang
Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, PR China
1 shared publication - Wenjuan Zhang
School of Life Sciences, Fudan University, Shanghai 200433, PR China
1 shared publication - Zhengdong Cai
Department of Orthopedic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, 200080, P. R. China
1 shared publication
Latest Publications
- Open Access
- 16 May 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 150
An integrative multi-platform analysis for discovering biomarkers of osteosarcoma
SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry) has become an attractive approach for cancer biomarker discovery due to its ability to resolve low mass proteins and high-throughput capability. However, the analytes from mass spectrometry are described only by their mass-to-charge ratio (m/z) values without further identification and annotation. To discover potential biomarkers for early diagnosis of osteosarcoma, we designed an integrative workflow combining data sets from both SELDI-TOF-MS and gene microarray analysis.
- 16 May 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 150
Open AccessAn integrative multi-platform analysis for discovering biomarkers of osteosarcoma
SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry) has become an attractive approach for cancer biomarker discovery due to its ability to resolve low mass proteins and high-throughput capability. However, the analytes from mass spectrometry are described only by their mass-to-charge ratio (m/z) values without further identification and annotation. To discover potential biomarkers for early diagnosis of osteosarcoma, we designed an integrative workflow combining data sets from both SELDI-TOF-MS and gene microarray analysis.